Physician profile
Dy Chin
NPI 1023768637
$3,182.01
in general payments reported to CMS, 2019-2025
13 companies · $3,182 in 2025
The $3,182 reported for 2025 was more than what 95% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $3,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,351 · Travel and Lodging: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,351.40 |
| Travel and Lodging | $830.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Core Surgical Group | $865.05 | 2025 | |
| Stryker Corporation | $544.46 | 2025 | Hoffmann, Flexband, Prostep Mica |
| Arthrex, INC. | $484.90 | 2025 | |
| Axogen | $253.52 | 2025 | |
| Pylant Medical | $236.72 | 2025 | |
| Treace Medical Concepts, INC. | $183.98 | 2025 | |
| Bioventus LLC | $146.99 | 2025 | Exogen Ultrasound Bone Healing System |
| Medshape, INC. | $146.60 | 2025 | Dynanail |
| Bone Support INC. | $146.11 | 2025 | Ceramentbone Void Filler, Cerament G |
| Biocomposites INC | $68.96 | 2025 | Stimulan |
| Orthofix Medical, INC. | $44.84 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $38.51 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Globus Medical, INC. | $21.37 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dy Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.